IMRX · Immuneering Corp
$5.21
+0.15 (+2.96%)
At close · Aug 17
Market Cap
$327.37M
Shares
64.70M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Benjamin Zeskind | President and Chief Executive Officer | $1,660,612 |
| Brett Hall | Chief Scientific Officer | $1,289,504 |
| Michael D. Bookman | Chief Legal Officer | $890,362 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Benjamin Zeskind | President and Chief Executive Officer | $1,945,092 |
| Brett Hall | Chief Scientific Officer | $1,425,506 |
| Michael D. Bookman | Chief Legal Officer | $1,088,351 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Benjamin Zeskind | President and Chief Executive Officer | $1,918,201 |
| Brett Hall | Chief Scientific Officer | $1,399,319 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Benjamin Zeskind | President and Chief Executive Officer | $2,054,966 |
| Brett Hall | Chief Scientific Officer Harold "E.B." Brakewood | $1,355,116 |
| Scott Barrett | Chief Medical Officer | $1,078,022 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Biren Amin | Chief Financial Officer | $3,273,530 |
| Benjamin Zeskind | President and Chief Executive Officer | $1,891,806 |
| Brett Hall | Chief Scientific Officer | $1,871,725 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Benjamin Zeskind | President and Chief Executive Officer | $806,045 |
| Brett Hall | Ph. D Chief Scientific Officer | $775,200 |
| Biren Amin | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Andrew Gengos | Chief Financial Officer and Treasurer | Appointed | 2026-06-15 |
| Thomas J. Schall, Ph.D. | Class I Director | Appointed | 2024-03-14 |
| Mallory Morales | Chief Accounting Officer and Treasurer | Appointed | 2023-06-14 |
| Biren Amin | Chief Financial Officer, principal financial officer, principal accounting officer and Treasurer | Resigned | 2022-07-25 |
| Diana F. Hausman | member of the Board of Directors as a Class I Director | Appointed | 2022-01-18 |
Key facts
CIK
1790340
CUSIP
45254E107
13F (30d)
107 filings
106 filers
Visit website
Investor relations